⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVGN News
EVOGENE LTD.
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
EVGN
Evogene Releases CEO Letter to Shareholders
prnewswire.com
EVGN
AI in Biotechnology Market Size to Reach USD 1,971 Million by 2031 | Valuates Reports
prnewswire.com
RXRX
EVGN
BNTX
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
prnewswire.com
EVGN
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
prnewswire.com
EVGN
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
prnewswire.com
EVGN
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
prnewswire.com
EVGN
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
prnewswire.com
EVGN
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
globenewswire.com
EVGN
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
prnewswire.com
EVGN